Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
View ORCID ProfileCory A. Perugino, Hang Liu, Jared Feldman, Blake M. Hauser, Catherine Jacob-Dolan, Anusha Nathan, Zezhou Zhou, Clarety Kaseke, Rhoda Tano-Menka, Matthew A. Getz, Fernando Senjobe, Cristhian Berrios, Onosereme Ofoman, Jacob E. Lemieux, Marcia B. Goldberg, Kerstin Nundel, Ann Moormann, Ann Marshak-Rothstein, John A. Iafrate, Gaurav Gaiha, Richelle Charles, Alejandro B. Balazs, View ORCID ProfileVivek Naranbhai, Aaron G. Schmidt, Shiv Pillai
doi: https://doi.org/10.1101/2021.12.30.21268554
Cory A. Perugino
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
2Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, MA 02114, USA
Hang Liu
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Jared Feldman
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Blake M. Hauser
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Catherine Jacob-Dolan
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
10Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston MA 02115
Anusha Nathan
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Zezhou Zhou
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Clarety Kaseke
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Rhoda Tano-Menka
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Matthew A. Getz
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Fernando Senjobe
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Cristhian Berrios
3Department of Pathology, Massachusetts Hospital, Boston, MA 02114, USA
Onosereme Ofoman
3Department of Pathology, Massachusetts Hospital, Boston, MA 02114, USA
Jacob E. Lemieux
4Infectious Diseases Division, Massachusetts Hospital, Boston, MA 02114, USA
5Broad Institute of MIT and Harvard, Cambridge MA 02139, USA
Marcia B. Goldberg
4Infectious Diseases Division, Massachusetts Hospital, Boston, MA 02114, USA
Kerstin Nundel
6University of Massachusetts Medical School, Worcester MA 01605, USA
Ann Moormann
6University of Massachusetts Medical School, Worcester MA 01605, USA
Ann Marshak-Rothstein
6University of Massachusetts Medical School, Worcester MA 01605, USA
John A. Iafrate
3Department of Pathology, Massachusetts Hospital, Boston, MA 02114, USA
Gaurav Gaiha
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
7Gastrointestinal Unit, Massachusetts Hospital, Boston, MA 02114, USA
Richelle Charles
4Infectious Diseases Division, Massachusetts Hospital, Boston, MA 02114, USA
Alejandro B. Balazs
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Vivek Naranbhai
8MGH Cancer Center, Massachusetts Hospital, Boston, MA 02114, USA
9Dana-Farber Cancer Institute, Boston, MA 02215, USA
10Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston MA 02115
Aaron G. Schmidt
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
11Department of Microbiology, Harvard Medical School, Boston MA 02115
Shiv Pillai
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
Posted January 01, 2022.
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
Cory A. Perugino, Hang Liu, Jared Feldman, Blake M. Hauser, Catherine Jacob-Dolan, Anusha Nathan, Zezhou Zhou, Clarety Kaseke, Rhoda Tano-Menka, Matthew A. Getz, Fernando Senjobe, Cristhian Berrios, Onosereme Ofoman, Jacob E. Lemieux, Marcia B. Goldberg, Kerstin Nundel, Ann Moormann, Ann Marshak-Rothstein, John A. Iafrate, Gaurav Gaiha, Richelle Charles, Alejandro B. Balazs, Vivek Naranbhai, Aaron G. Schmidt, Shiv Pillai
medRxiv 2021.12.30.21268554; doi: https://doi.org/10.1101/2021.12.30.21268554
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
Cory A. Perugino, Hang Liu, Jared Feldman, Blake M. Hauser, Catherine Jacob-Dolan, Anusha Nathan, Zezhou Zhou, Clarety Kaseke, Rhoda Tano-Menka, Matthew A. Getz, Fernando Senjobe, Cristhian Berrios, Onosereme Ofoman, Jacob E. Lemieux, Marcia B. Goldberg, Kerstin Nundel, Ann Moormann, Ann Marshak-Rothstein, John A. Iafrate, Gaurav Gaiha, Richelle Charles, Alejandro B. Balazs, Vivek Naranbhai, Aaron G. Schmidt, Shiv Pillai
medRxiv 2021.12.30.21268554; doi: https://doi.org/10.1101/2021.12.30.21268554
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2913)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12699)
- Forensic Medicine (12)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4557)
- Geriatric Medicine (414)
- Health Economics (724)
- Health Informatics (2908)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4324)
- Nursing (233)
- Nutrition (634)
- Oncology (2256)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1196)
- Primary Care Research (493)
- Public and Global Health (6909)
- Radiology and Imaging (1522)
- Respiratory Medicine (914)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)